Biomea Fusion, Inc. (BMEA)
NMS – Real vaqt narxi. Valyuta: USD
1.32
-0.05 (-3.65%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
1.32
0.00 (0.00%)
Bozordan keyin: Mar 27, 2026, 6:54 PM EDT

NMS – Real vaqt narxi. Valyuta: USD
1.32
-0.05 (-3.65%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
1.32
0.00 (0.00%)
Bozordan keyin: Mar 27, 2026, 6:54 PM EDT
Biomea Fusion, Inc., klinik bosqichdagi diabet va semirish dorilari kompaniyasi, Qo'shma Shtatlarda metabolik kasalliklari bo'lgan bemorlarni davolash uchun og'iz orqali qabul qilinadigan kovalent kichik molekulali dorilarni kashf qilish va ishlab chiqishga qaratilgan. Uning asosiy mahsulot nomzodi ikovamenib, og'iz orqali biologik mavjud bo'lgan, kuchli va kovalent menin ingibitori hisoblanadi. Menin – bu giston modifikatsiyasi va epigenetik gen regulyatsiyasida ishtirok etadigan, hujayra siklini nazorat qilish, apoptoz va DNK shikastlanishini tiklash kabi ko'plab hujayra jarayonlariga ta'sir ko'rsatadigan keng tarqalgan skafold oqsili. Biomea Fusion, Inc. 2017 yilda tashkil etilgan va shtab-kvartirasi San-Karloss, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Caroline Perez- Dupont J.D. | Senior Vice President of Contracts |
| Dr. Michael J. M. Hitchcock Ph.D. | Interim CEO & Director |
| Dr. Stephan Morris M.D. | Chief Development Officer |
| Dr. Thorsten Kirschberg Ph.D. | Executive Vice President of Research |
| Mr. Heow Tan | Chief Technology & Quality Officer |
| Mr. Ramses M. Erdtmann | Co-Founder, President, COO & Director |
| Mr. Ravi Upasani Ph.D. | Executive Vice President of Intellectual Property |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-01-14 | 8-K | d747443d8k.htm |
| 2026-01-06 | S-8 | d10984ds8.htm |
| 2025-11-04 | 10-Q | bmea-20250930.htm |
| 2025-10-07 | 8-K | d237219d8k.htm |
| 2025-10-06 | 8-K | d79150d8k.htm |
| 2025-08-13 | CORRESP | filename1.htm |
| 2025-08-05 | S-3 | bmea-20250805.htm |
| 2025-07-24 | 8-K | d57486d8k.htm |
| 2025-06-20 | 8-K | d877313d8k.htm |
| 2025-06-18 | 8-K | d44604d8k.htm |